Herb Cross

Herb Cross is the Chief Financial Officer at Jasper Therapeutics since September 2023 and serves as a Board Member for The Association of Bioscience Financial Officers International. Previously, Herb held positions as Board Member and Audit Committee Chair at Apexigen and DNAtrix, and served as Chief Financial Officer for multiple biotech companies, including Atreca, Inc., ARMO BioSciences, Balance Therapeutics Inc., KaloBios Pharmaceuticals, and Affymax. Herb's early career included a role as Vice President of Finance at Facet Biotech. Herb Cross earned a Bachelor of Science in Finance and Accounting from the University of California, Berkeley, Haas School of Business, from 1989 to 1994.